Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015–2019)

C Sánchez-Martínez, MJ Lallena… - Bioorganic & medicinal …, 2019 - Elsevier
Sustained proliferative capacity and gene dysregulation are hallmarks of cancer. In
mammalian cells, cyclin-dependent kinases (CDKs) control critical cell cycle checkpoints …

Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer

M Mortazavi, F Moosavi, M Martini, E Giovannetti… - Critical reviews in …, 2022 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) has one of the worst prognoses among all
malignancies. PI3K/AKT/mTOR signaling pathway, a main downstream effector of KRAS is …

[HTML][HTML] Phytochemicals as potential anticancer drugs: time to ponder nature's bounty

MA Ashraf - BioMed research international, 2020 - hindawi.com
Medicinal plants have been used from the beginning of human civilization, which is mostly
evident from the ancient script and traditional herbal medicine recipe. Despite the historically …

Saponins in cancer treatment: Current progress and future prospects

OO Elekofehinti, O Iwaloye, F Olawale, EO Ariyo - Pathophysiology, 2021 - mdpi.com
Saponins are steroidal or triterpenoid glycoside that is distinguished by the soap-forming
nature. Different saponins have been characterized and purified and are gaining attention in …

E3 ubiquitin ligase TRIM proteins, cell cycle and mitosis

S Venuto, G Merla - Cells, 2019 - mdpi.com
The cell cycle is a series of events by which cellular components are accurately segregated
into daughter cells, principally controlled by the oscillating activities of cyclin-dependent …

The involvement of ubiquitination machinery in cell cycle regulation and cancer progression

T Zou, Z Lin - International journal of molecular sciences, 2021 - mdpi.com
The cell cycle is a collection of events by which cellular components such as genetic
materials and cytoplasmic components are accurately divided into two daughter cells. The …

Anticancer effects with molecular docking confirmation of newly synthesized isatin sulfonamide molecular hybrid derivatives against hepatic cancer cell lines

M Eldeeb, EF Sanad, A Ragab, YA Ammar… - Biomedicines, 2022 - mdpi.com
The current study investigated the cytotoxic effect of ten sulfonamide-derived isatins,
following molecular hybridization, based on the association principles, on hepatocellular …

[HTML][HTML] Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: An underestimated truth

V Yadav, P Talwar - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Increasing development costs and higher failure rate in clinical trials has reduced the
repertoire of newer drugs in the market for clinical use. The most appropriate approach to …

Lessons learned from past cyclin-dependent kinase drug discovery efforts

Z Xie, S Hou, X Yang, Y Duan, J Han… - Journal of Medicinal …, 2022 - ACS Publications
Inhibition of cyclin-dependent kinases (CDKs) has become an effective therapeutic strategy
for treating various diseases, especially cancer. Over almost three decades, although great …

Novel 1, 3, 5-triazine-based pyrazole derivatives as potential antitumor agents and EFGR kinase inhibitors: Synthesis, cytotoxicity, DNA binding, molecular docking …

MS Raghu, CBP Kumar, MK Prashanth… - New Journal of …, 2021 - pubs.rsc.org
We herein report the design and synthesis of new 1, 3, 5-triazine-based pyrazole derivatives
(5a–i) with anticancer activity targeting the epidermal growth factor (EGFR) tyrosine kinase …